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Abstract.  Α DNA synthesis inhibitor protein was purified from the conditioned medium
of cycloheximide treated mouse embryo fibroblasts. This protein has a molecular weight of 
45,000 as determined by gel filtration and Polyacrylamide gel electrophoresis. The levels of 
the [35S] methionine la belled 45 kDa protein in the medium and matrix were monitored 
across two cell cycles in synchronized cultures. The 45 kDa protein was present in higher 
levels in the medium of non-S-phase cells depicting a peak between the two S- phases. The 
DNA synthesis inhibitor protein was immunologically related to a chicken DNA-binding 
protein which showed similar cell cycle specific variations at the intracellular level. The 
purified 45 kDa protein inhibited DNA synthesis in murine and human cells. In mouse 
embryo fibroblasts, the DNA synthesis was inhibited to an extent of 86% by 0·25 µg/ml of 
the inhibitor, while higher amounts of the inhibitor were required to arrest DNA synthesis 
in human skin fibroblasts: in these cells, 4 µg/ml of the inhibitor inhibited DNA synthesis 
to an extent of 50%. The high levels of the 45 kDa protein in the medium of non-S phase 
cells and its DNA synthesis inhibitory potential suggest that this protein may be involved 
in the regulation of DNA synthesis during the cell cycle.
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1.   Introduction 
 
The molecular mechanisms of regulation of cell growth by the endogenous proteins 
of the cell are of increasing interest. The role of autocrine growth factors in the 
stimulation of cell proliferation has been studied in detail (James and Bradshaw 
1984; Heldin and Westermark 1984). However, much less is known about the role 
of endogenous growth inhibitor proteins on cell growth. A number of growth 
inhibitory proteins have been purified and characterized from various types of cells 
(Holley et al 1980; Harel et al 1985; Hsu and Wang 1986; Stein and Atkins 1986; 
Feltham et al 1987; Ervin et al 1989). Recently, transforming growth factor β was 
shown to act as a bifunctional modulator of cell growth (Roberts et al 1985). A 
secreted protein of molecular weight (Mr) 48,000 identified as plasminogen 
activator inhibitor-1 was suggested to be involved in the regulation of cell proli- 
feration (Nagashunmugam et al 1989; Srinivas et al 1990).
We have recently shown that the conditioned media of non-S-phase fibroblast 
cultures contained large quantities of a 45 kDa protein, and this conditioned 
medium inhibited DNA synthesis (Nagashunmugam and Shanmugam 1987). In 
studies described here, the 45 kDa protein was purified from the conditioned 
medium of mouse embryo fibroblasts (MEF).The purified protein was shown to 
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inhibit DNA synthesis in murine and human cells. Studies on the levels of the 
45 kDa protein across two cell cycles and its immunological relatedness to a 
chicken DNA binding protein (Matsuhashi et al 1987) that showed similar cell cycle 
specific variations are also described.
 
 
2.    Materials and methods 
 
2.1   Synchronization of Cells 
 
Primary cultures of Swiss MEF were grown in Eagle’s minimal essential medium 
(MEM) (Flow Labs., UK) containing 10% bovine serum (Flow Labs, UK) and 
gentamycin (50 µg/ml) at 37°C. Cells from the fourth passage onwards (secondary 
cultures) were used for experiments. Sub-confluent monolayers were synchronized 
by a double block method first at quiescence by growing for 48-72 h in 0·5% 
serum-containing medium and then at G1/S junction by treatment with 1 mM 
hydroxyurea (HOU) in MEM containing 10% bovine serum for 16 h. The human 
skin fibroblasts (LN 9 cells) were obtained from Dr Μ Digweed, and these cells 
were also synchronized as above. Cells were relieved of HOU arrest by 
washing the monolayers thrice with phosphate buffered saline followed by 
incubation in 10% serum-containing medium.
 
 
2.2   Protein purification 
 
Quiescent monolayers in rollers were first treated with cycloheximide (3 µg/ml) for 
15 h and then maintained for 1 h in serum-free MEM. One hundred ml of 
conditioned medium were concentrated to 0·5 ml by ultrafiltration using a 10 kDa 
cut-off Millipore membrane. The concentrated sample was fractionated in a LKB 
HPLC system using size-exclusion column (7·5 × 600 mm, TSK G-3000). The 
proteins were eluted with 20 mM Tris-HCl pH 7·2 and 1 mM EDTA at a flow rate 
of 0·2 ml/min and 0·5 ml fractions were collected. The molecular weights of the 
eluted proteins were estimated using proteins of known molecular weights. The 
peak fractions were pooled, lyophilized and dissolved in phosphate buffered saline 
(PBS). The protein solution was then filter-sterilized and assayed for DNA synthesis 
inhibitory activity. The protein concentration was determined according to Lowry 
et al (1951). 
 
 
2.3    Inhibitor assay 
 
DNA synthesis inhibitory activity was assayed using MEF and LN9 cells grown in 
24 well plates. Each well contained 2 × 104 cells in 0·5 ml of growth medium. Cells 
were synchronized by HOU treatment as mentioned earlier. The HOU arrested 
MEF and LN9 cells were washed thrice with PBS and maintained in fresh growth 
medium in the presence or absence of purified DNA synthesis inhibitor protein. The 
DNA synthesis was monitored by labelling the cells with 5 μCi/ml [3H] thymidine 
for 30 min after 2 h of release from HOU arrest. At the end of labelling, the cells in 
the wells were washed thrice with cold PBS and acid precipitable radioactivity was 
determined (Russell et al 1984).
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2.4    Gel electrophoresis 
 
The HOU arrested and stimulated monolayers (25 cm2) were washed twice with 
PBS and labelled with 25 μCi of [35S] methionine for 30 min in 2 ml of Hanks 
balanced salt solution. The radioactivity was later chased for 30 min in serum-free 
medium. The secreted and the extracellular matrix proteins were isolated as 
described earlier (Nagashunmugam et al 1989), electrophoresed in 5–18% 
Polyacrylamide gradient gels containing sodium dodecyl sulphate (SDS) and 
fluorographed (Nagashunmugam et al 1989). The relative amounts of the 45 kDa 
protein was deduced by laser densitometry of the fluorograms.
 
 
3.    Results 
 
In our previous studies, we have identified a group of early growth response 
proteins in MEF (Subramaniam and Shanmugam 1985, 1986a, 1987, 1988). One of 
these, the 45 kDa protein was present in large amounts in the growth medium of 
non-S-phase cells. Of all the secreted proteins of MEF, the 45,000 dalton protein 
was super-induced by cycloheximide treatment (figure 1). For these studies, 
quiescent cells were treated with cycloheximide (CH) (3 μg/ml) for 15 h after which 
the CH containing medium was removed and the cells were labelled with 
[35S] methionine for 30 min. The radioactivity was then chased for different periods 
in serum-free chase-medium. Figure 1 shows the fate of the labelled 45 kDa protein 
at different periods of chase. The 45 kDa protein was the major secreted protein in 
the medium of CH treated cells in the first 1 h of chase. Other proteins started to 
accumulate in the medium from 2 h onwards.
 
 
3.1    45 kDa protein levels in synchronized cells 
 
When the DNA synthesis of synchronized cells that were released from HOU-arrest 
was monitored by labelling with [3H] thymidine, two peaks of DNA synthesis (one 
at 3 h and the other at 24 h after release) were observed (figure 2). The levels of the 
45 kDa protein was quantitated at various periods after release from HOU-arrest
by labelling the cells with [35S] methionine and analysing the labelled secreted 
proteins present in the chase-medium. In our previous studies we observed a decline 
in the level of the 45 kDa secreted protein as the cells entered into peak DNA 
synthesis (Nagashunmugam and Shanmugam 1987). Here, we report a second 
decrease in the level of the 45 kDa protein at the beginning of the second S-phase; 
this decline continued up to the peak of DNA synthesis of the second S-phase 
(figure 2). When the levels of the 45 kDa protein were quantitated by laser 
densitometry, a 3-4-fold decrease in its level was observed at the first and second S- 
phase peaks, in comparison to its level in the culture media of non-S-phase cells 12– 
18 h after release from HOU arrest. 
 
3.1a  45 kDa protein is a component of extracellular matrix: Some of the secreted 
proteins like fibronectin and vitronectin are extracellular matrix components. These 
proteins were shown to have important roles in cell adhesion and cell-cell
communication. Therefore, we looked for the presence of the 45 kDa protein in the 
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Figure 1. Secreted proteins of cycloheximide treated cells. Quiescent MEF were 
incubated with CH (3 µg/ml) containing medium for 15 h. At the end of incubation. CH-
containing medium was removed, cells were washed and then labelled with 
[35S] methionine for 30 min. After this pulse-labelling, the radioactive medium was 
removed, cells were washed and then incubated for different periods in serum free chase- 
medium. The labelled proteins secreted into the medium were analysed by electrophoresis 
in 5 to 18% Polyacrylamide gradient gels containing SDS. The protein bands were 
visualized by fluorography. The numbers at the top of the lanes indicate hours of 
incubation of labelled cells in the chase-medium. 
 
 
 
extracellular matrix and the results are shown in figure 3. Maximum levels of the 
45 kDa protein were observed in both the matrix and medium at 12 h after release 
from HOU arrest; at this time, the DNA synthesis declined to background levels. 
When the DNA synthesis went up in the second S-phase (20 h onwards), the 
amount of the matrix-associated 45 kDa protein also declined. The major 
component of the extracellular matrix of MEF is a 48 kDa protein identified as 
plasminogen activator inhibitor (Nagashunmugam et al 1989), this protein did not 
show any spectacular variation across the cell cycle as that exhibited by the 45 kDa 
protein. However, a slight decrease in the level of the 48 kDa protein at 12 h after 
release of cells from HOU arrest was observed (figure 4); at this time (12 h after 
HOU release), the cells were expected to be at mitosis and the cells had a rounded 
shape. The decreased level of the protease inhibitor al the time of mitosis may 
correlate with increased pericellular proteolytic activity which results in the 
disruption of anchorage of these cells enabling them to become round and loosely 
attached to the substratum.
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Figure 2.  Levels of 45 kDa protein in the growth medium across two S-phases.
One set of MEF that were released from HOU-arrest were pulse-labelled for 30 min with 
[35S] methionine at the indicated periods after release. Another set was labelled for 30 min 
with [3H] thymidine under the same conditions. [3H] thymidine incorporation into DNA 
was estimated from TCA-insoluble counts. [35S] methionine-labelled secreted proteins 
were isolated and electrophoresed in Polyacrylamide gradient gels as described under § 2·4. 
[35S] methionine incorporation into the secreted 45 kDa protein is represented as the 
intensity of the radioactive 45 kDa protein. The intensity was quantitated by laser 
densitometry of the 45 kDa protein bands of the fluorograms of gels in which the proteins 
were electrophoresed.
 
 
3.2   45 kDa protein is related to P28 DBP
 
Matsuhashi et al (1987) have shown that a 45 kDa protein present in serum- 
stimulated NIH 3T3 cells reacted with a monoclonal antibody raised against a 
chicken DNA binding protein called P28. The P28 protein was shown to be 
synthesized in the cells during late G1 and the synthesis of this protein ceased at the 
S-phase (Matsuhashi et al 1987). To establish the relatedness of these proteins, the 
45 kDa DNA synthesis inhibitor protein secreted by MEF was reacted with 
monoclonal antibody against P28 antigen. Figure 4 shows the electrophoretic 
profile of immunoprecipitated proteins of medium and matrix. The electrophoretic 
pattern shows a 45 kDa protein as the sole labelled protein of the 
immunoprecipitate, indicating that the 45 kDa protein is related to the P28 antigen. 
 
 
3.3   DNA synthesis inhibition by purified 45 kDa protein
 
For the purification of the 45 kDa protein, cells were grown in roller bottles and 
treated with cycloheximide for 15 h; the first hour conditioned media of these 
cultures were collected, clarified and concentrated by ultrafiltration. The 
concentrated medium was chromatographed in TSK 3000 HPLC column. Figure 5 
shows the elution profile of the 45 kDa protein which coincides with the ovalbumin 
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Figure 3.   Levels of 45 kDa protein in the extracellular matrix across two S-phases.
One set of MEF that were released from HOU-arrest were pulse labelled for 30 min with 
[35S] methionine. Labelled cells were removed at the indicated periods after release and 
the extracellular matrix proteins were isolated as described in §2·2. The labelled proteins 
were resolved by 5-18% PAGE and fluorographed. A 48 kDa protein identified previously 
as plasminogen activator inhibitor and the 45 kDa protein were the predominant 
components of the extracellular matrix. The intensities of the labelled 48 and 45 kDa 
protein bands were quantitated by laser densitometry. Another set of MEF were labelled 
for 30 min with [3H] thymidine under the same conditions, and the thymidine 
incorporation into DNA was determined from TCA-insoluble radioactivity.
 
 
retention time. The 45 kDa protein fractions were pooled, lyophilized and dissolved 
in PBS. After filter sterilization, the protein was used in DNA synthesis inhibition 
assays. 
Cells synchronized in G1/S border by the double block method were released by 
the addition of medium containing 20% foetal calf serum, in the presence or absence 
of column fractions. No inhibition of DNA synthesis was observed with fractions 
lacking the 45 kDa protein. Figure 6a shows the inhibition of DNA synthesis in 
MEF in the presence of various concentrations of the 45 kDa protein. Maximum 
DNA synthesis inhibition was observed at and above 0·25 µg/ml of inhibitor in 
MEF (figure 6a). The DNA synthesis inhibitory activity was found to be dose- 
dependent, and the half maximal inhibitory activity, calculated from figure 6a, was 
at 0·15 µg/mml of the 45 kDa protein. No DNA synthesis inhibitory activity was 
observed at this concentration in LN9 human fibroblasts. However, at higher 
concentration of the inhibitor, the DNA synthesis in these cells was also inhibited. 
In human fibroblasts, maximum inhibition of DNA synthesis (53%) was achieved 
with 4 µg/ml of the inhibitor protein and half maximum inhibition was observed 
with 1 µg/ml of the inhibitior (figure 6b).
Maximum inhibition of DNA synthesis was observed at 2 h after addition of the 
inhibitor in cells released from HOU arrest (figure 7). DNA synthesis was inhibited 
to an extent of 45% at l h and 84% after 2h of treatment of MEF with the 
inhibitor. Later, a gradual increase in [3H] thymidine incorporation in inhibitor 
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Figure  4.   Immunoprecipitation of 45 kDa protein.
MEF 12 h after release from HOU arrest were labelled with [35S] methionine for 30 min. 
Following a 30 min chase incubation, the labelled medium and extracellular matrix proteins 
were isolated as described in §2.4. For immunoprecipitation, antibodies to P28 protein pro- 
vided by Dr Κ Hori was used and the method described by Srinivas et al (1990) was followed. 
The immunoprecipitates were analysed by SDS-PAGE and fluorographed. (A), secreted 
proteins of conditioned medium; (B), extracellular matrix proteins; (C), immunoprecipitate 
of proteins from conditioned medium; (D), immunoprecipitate of proteins from 
extracellular matrix. In each case proteins derived from one 75 cm2 monolayer was used. 
 
 
treated cells was observed which reached a maximum at 7 h after release from 
HOU arrest. During this period, only a basal level of DNA synthesis was observed 
in control cells that were released from HOU arrest in the absence of inhibitor 
protein. The growth inhibition after 7 h of release from HOU arrest was 56% of the 
maximum incorporation observed in control cells 3 h after release from HOU 
arrest. The decrease in the inhibitory activity of the protein after its presence for 
longer periods in the medium may be due to the inactivation of the protein. The 
DNA synthesis inhibitory activity was destroyed by heating the inhibitor protein at 
60°C for 1 h. 
 
 
4.    Discussion 
 
The results presented here show that secondary cultures of MEF secrete a growth 
inhibitory protein whose secretion is regulated during the cell cycle. The amount of 
the 45 kDa protein in the conditioned medium of S-phase cells was about one- 
fourth of that observed at G2 and other phases, suggesting an inverse correlation 
between DNA synthesis and the levels of the 45 kDa secreted protein.
DNA synthesis inhibitory proteins have been identified from the membranes of 
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Figure 5. Purification of 45 kDa protein.
Conditioned media from cycloheximide treated MEF were concentrated by ultrafiltration 
(see §2·2) and chromatographed in a size exclusion (TSK 3000) HPLC column. The main 
figure shows the elution profile of the 45 kDa protein while the inset dipicts molecular 
weight calibration in which the retention times of standard marker proteins and the 45 
kDa protein were ploted against log molecular weight.
 
quiescent and senescent human fibroblasts (Feltham et al 1987) and from the 3T3 
cell plasma membranes (Whittenberger and Glaser 1977). Low molecular weight 
polypeptide inhibitors of DNA synthesis have been identified in the medium of 
mouse fibroblasts (Wells and Mallucci 1983). A 45,000 dalton protein called 
inhibitory diffusible factor (IDF) has been purified from the conditioned medium of 
density arrested NIH 3T3 cells and the N-terminal amino acid sequence of this 
protein has been determined (Blat et al 1989). Bohmer et al (1987) have shown that 
antibodies raised against bovine mammary derived growth inhibitor react with 
mouse fibroblast growth inhibitor.
Subramaniam and Shanmugam (1985, 1987, 1988) have shown that quiescent 
MEF secrete several proteins upon serum-stimulation. The results presented here 
show that among the secreted proteins, the 45 kDa protein alone is superinduced 
by cycloheximide treatment. The superinduction of the 45 kDa protein by CH 
suggests that the synthesis of this protein may be under the control of a labile 
repressor protein. Similar conclusion was also arrived at for the other CH-inducible 
proteins (Kruijer et al 1984; Makino et al 1984; Subramaniam and Shanmugam 
1986b). The inhibition of extracellular levels of the 45 kDa protein by actinomycin- 
D (Subramaniam and Shanmugam 1988) shows that the synthesis and secretion of 
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Figure 6.   (A) Effect of purified 45 kDa protein on DNA synthesis in MEF.
The growth of MEF were arrested at G1/S junction by HOU treatment for 15 h. At the 
end of this period, HOU was removed, cell monolayers were washed and incubated for 
2·5 h in fresh growth medium containing the indicated amounts of 45 kDa protein after 
which they were incubated another 30 min with [3H] thymidine. HOU released control 
monolayers were similarly incubated for 2·5 h in fresh medium followed by 30 more min in 
medium containing [3H] thymidine. Per cent inhibition of DNA synthesis was determined 
from the TCA insoluble radioactivities of control and 45 kDa protein treated monolayers. 
(Β) Effect of purified 45 kDa protein on DNA synthesis in LN9 human fibroblasts. The 
protocol followed for this study is identical to that described above for MEF.
 
 
 
Figure 7.   Time course of inhibition of DNA synthesis by the 45 kDa protein.
Monolayers of MEF were labelled for 30 min with [3H] thymidine (5 µCi/ml) at the 
indicated periods after release from HOU arrest in the presence or absence of the 45 kDa 
protein (0·3 µg/ml). DNA synthesis was monitored by determining TCA insoluble 
radioactivity. The X-axis indicates time (in hours) after release of cells from HOU arrest. In 
the case of control, the cells were released from HOU arrest by using fresh medium 
containing foetal calf serum. To monitor DNA synthesis in the presence of the inhibitor, 
the cells were released from HOU arrest using fresh medium containing foetal calf serum and 
the 45kDa protein; these cultures were later labelled with [3H] thymidine. (Ο), DNA 
synthesis in control cells; (●), DNA synthesis in 45 kDa protein-treated cells.
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this protein involve newly made mRNA species. Santaren and Bravo (1987) 
observed a similar superinduction of a 45 kDa protein by CH in 3T3 cells and the 
synthesis of this protein was also inhibited by actinomycin-D.
The 45 kDa protein was the first protein that appeared in the medium within 30 
min chase incubation of pulse-labelled cells. Since high extracellular levels of the 45 
kDa protein were observed in the conditioned medium within an hour of CH 
treatment, this antibiotic was used to enrich this protein selectively for purification 
purposes. 
Extracellular matrix proteins like fibronectin, vitronectin, collagen and laminin 
play important roles in cell substrate adhesion and cell-cell interaction by binding 
against specific cell surface receptors (Kleinman et al 1981; Hasegawa et al 1985; 
Yamada et al 1985; Laptin 1986; Hynes 1987). One of the 45 kDa secreted proteins 
of 3T3 cells was a glycoprotein associated with extracellular matrix (Santaren and 
Bravo 1987). In our studies, the matrix associated 45 kDa protein showed 
variations across cell cycle, while the major matrix protein (PAI-1) showed little 
variation (figure 4).
Matsuhashi et al (1987) identified a 45 kDa protein in NIH 3T3 cells whose 
intracellular level was regulated during cell cycle; the synthesis of this protein 
ceased during S-phase. A monoclonal antibody (P28) raised against a chicken DNA 
binding protein reacted with the intracellular 45 kDa protein of NIH 3T3 cells 
(Matsuhashi et al 1987). Here, we show that the secreted and the matrix associated 
45 kDa proteins of MEF, are immunologically related to the 45 kDa protein of 
NIH 3T3 cells. Also the 45 kDa DNA synthesis inhibitory factor described here is 
similar in molecular weight and mode of action to the IDF 45 described by Harel et 
al (1985). Further characterization of this protein is necessary to confirm its 
identity with IDF 45. Experiments are underway for sequencing this protein.
Several mechanisms may be postulated for the inhibitory action of 45 kDa 
protein on DNA synthesis. The protein may inhibit the transport of [3H] thymidine 
or deplete the intracellular nucleotide pool. Also it is not known whether the 45 
kDa protein is internalized by specific receptors or by other mechanisms. The 
ongoing studies in our laboratory are aimed at unravelling the mechanism of action 
of this protein on the inhibition of DNA synthesis.
The 45 kDa DNA synthesis inhibitor protein might be one among the negative 
growth regulators that control the proliferation of cells triggered by positive growth 
regulators such as mitogens (Stocker 1973; Stocker and Piggolt 1974). Future 
directions of these studies include raising of antibodies and DNA clones to the 45 
kDa protein and its gene to understand the role of this protein in cell proliferation. 
Preliminary studies showed reduced levels of this protein in rapidly proliferating 
oncogene (myc-ras) transformed rat cells (M V V S Varaprasad and G Shanmugam, 
unpublished results). Higher amounts of the 45 kDa protein in normal cells may 
exert a negative control in these cells and regulate the rate of cell division.
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